| RS | LS | Total |
---|---|---|---|
Median age (min–max) | 71 (13–108) | 63 (11–106) | 67 (11–108) |
Gender | |||
 Male | 22.99 | 27.58 | 50.57 |
 Female | 27.64 | 21.79 | 49.43 |
Race (%) | |||
 White | 40.65 | 38.82 | 79.47 |
 Black | 6.52 | 4.99 | 11.51 |
 Asian | 2.84 | 4.73 | 7.57 |
 Other | 0.61 | 0.85 | 1.46 |
Stage at presentation (%) | |||
 Stage 0 | 0.61 | 0.50 | 1.11 |
 Stage I | 10.67 | 11.23 | 21.90 |
 Stage II | 16.67 | 13.66 | 30.32 |
 Stage III | 15.53 | 17.53 | 33.06 |
 Stage IV | 7.14 | 6.46 | 13.60 |
Histologic subtype (%) | |||
 Adenocarcinoma | 43.49 | 46.04 | 89.54 |
 Mucinous adenocarcinoma | 5.67 | 2.69 | 8.37 |
 Other | 1.45 | 0.64 | 2.10 |
Histologic grade (%) | |||
 Well differentiated | 4.33 | 4.21 | 8.54 |
 Moderately differentiated | 33.63 | 37.77 | 71.40 |
 Poorly differentiated | 10.85 | 6.58 | 17.43 |
 Undifferentiated | 1.81 | 0.82 | 2.63 |
Adequate lymph node examination (more than 12 nodes) (%) | |||
 Yes | 41.94 | 34.62 | 76.56 |
 No | 8.57 | 14.60 | 23.17 |
 Missing data | 0.11 | 0.16 | 0.27 |
Type of surgery (%) | |||
 Local excision | 0.06 | 0.39 | 0.45 |
 Partial colectomy | 9.93 | 34.68 | 44.60 |
 Hemicolectomy | 39.34 | 8.43 | 47.77 |
 Total colectomy | 0.70 | 4.34 | 5.04 |
 Other colectomy | 0.55 | 1.38 | 1.94 |
 No surgery | 0.04 | 0.15 | 0.19 |
Chemotherapy (%) | |||
 Yes | 15.59 | 24.48 | 40.07 |
 No/unknown | 35.03 | 24.90 | 59.93 |
Radiation therapy (%) | |||
 Yes | 0.53 | 12.26 | 12.79 |
 No/unknown | 50.09 | 37.12 | 87.21 |